36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
18 °P sammeln
  • Broschiertes Buch

Liver diseases are often associated with abnormal bleeding and show multiple, complicated hemostatic abnormalities primarily due to clotting factor deficiency and secondarily due to thrombocytopenia and platelet dysfunction. Though the prevalence of platelet dysfunction in cirrhosis is reported, the data regarding the specific defect is lacking. The strategy is to develop an effective drug treatment that can focus on the exact platelet activation defect to reduce the bleeding complication in cirrhosis patients. This book deals with the influence of cytosolic calcium, cGMP, nitric oxide and…mehr

Produktbeschreibung
Liver diseases are often associated with abnormal bleeding and show multiple, complicated hemostatic abnormalities primarily due to clotting factor deficiency and secondarily due to thrombocytopenia and platelet dysfunction. Though the prevalence of platelet dysfunction in cirrhosis is reported, the data regarding the specific defect is lacking. The strategy is to develop an effective drug treatment that can focus on the exact platelet activation defect to reduce the bleeding complication in cirrhosis patients. This book deals with the influence of cytosolic calcium, cGMP, nitric oxide and nitric oxide synthase on platelet functions such as adhesion, aggregation and secretion in liver cirrhosis patients and the results might throw light on the future insights of platelet research towards bleeding complication in liver cirrhosis.
Autorenporträt
The author, an academician and active researcher has made extensive contributions in the field of basic medical sciences. Her main interests are hepatobiliary disorders, platelet research, medicinal plant research, food antioxidants and free radicals in health and diseases.